Advanced search
Publication Cover
Leukemia & Lymphoma Volume 55, 2014 - Issue 5
Submit an article Journal homepage
470
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Combination of rituximab and mammalian target of rapamycin inhibitor everolimus (RAD001) in diffuse large B-cell lymphoma

Zi-Zhen XuDepartment of Laboratory Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai, China;Department of Hematology, Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China
,
Wen-Fang WangDepartment of Hematology, Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China
,
Wan-Bin FuDepartment of Hematology, Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China
,
Ai-Hua WangDepartment of Hematology, Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China
,
Zhi-Yin LiuDepartment of Hematology, Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China
,
Li-Yun ChenDepartment of Hematology, Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China
,
Pei GuoDepartment of Hematology, Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China
&
Jun-Min LiDepartment of Hematology, Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, ChinaCorrespondence[email protected]
 show all
Pages 1151-1157 | Received 07 Apr 2013, Accepted 03 Jul 2013, Published online: 28 Aug 2013

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Piotr Smolewski & Tadeusz Robak. (2015) The preclinical discovery of rituximab for the treatment of non-Hodgkin’s lymphoma. Expert Opinion on Drug Discovery 10:7, pages 791-808.
Read now
Patrizia Mondello & Anas Younes. (2015) Emerging drugs for diffuse large B-cell lymphoma. Expert Review of Anticancer Therapy 15:4, pages 439-451.
Read now

Articles from other publishers (10)

Bodo C. Melnik, Rudolf Stadler, Ralf Weiskirchen, Claus Leitzmann & Gerd Schmitz. (2023) Potential Pathogenic Impact of Cow’s Milk Consumption and Bovine Milk-Derived Exosomal MicroRNAs in Diffuse Large B-Cell Lymphoma. International Journal of Molecular Sciences 24:7, pages 6102.
Crossref
Yaxin Zheng, Junqi Si, Tian Yuan, Sa Ding & Chen Tian. (2021) Immune targeted therapy for diffuse large B cell lymphoma. Blood Science 3:4, pages 136-148.
Crossref
Stefania Crisci, Raffaele Di Francia, Sara Mele, Pasquale Vitale, Giuseppina Ronga, Rosaria De Filippi, Massimiliano Berretta, Paola Rossi & Antonio Pinto. (2019) Overview of Targeted Drugs for Mature B-Cell Non-hodgkin Lymphomas. Frontiers in Oncology 9.
Crossref
Jean-Ehrland Ricci & Johanna Chiche. (2018) Metabolic Reprogramming of Non-Hodgkin's B-Cell Lymphomas and Potential Therapeutic Strategies. Frontiers in Oncology 8.
Crossref
Wendan Xu, Ji-Won Kim, Woo June Jung, Youngil Koh & Sung-Soo Yoon. (2018) Crizotinib in Combination with Everolimus Synergistically Inhibits Proliferation of Anaplastic Lymphoma Kinase‒Positive Anaplastic Large Cell Lymphoma. Cancer Research and Treatment 50:2, pages 599-613.
Crossref
Jens Hasskarl. 2018. Small Molecules in Oncology. Small Molecules in Oncology 101 123 .
Yaghoub Safdari, Vahideh Ahmadzadeh & Safar Farajnia. (2016) CD20-targeting in B-cell malignancies: novel prospects for antibodies and combination therapies. Investigational New Drugs 34:4, pages 497-512.
Crossref
Scott A. Ezell, Suping Wang, Teeru Bihani, Zhongwu Lai, Shaun E. Grosskurth, Suprawee Tepsuporn, Barry R. Davies, Dennis Huszar & Kate F. Byth. (2016) Differential regulation of mTOR signaling determines sensitivity to AKT inhibition in diffuse large B cell lymphoma. Oncotarget 7:8, pages 9163-9174.
Crossref
Ronit Vogt Sionov, Spiros A. Vlahopoulos & Zvi Granot. (2015) Regulation of Bim in Health and Disease. Oncotarget 6:27, pages 23058-23134.
Crossref
Michele Merli, Andrea Ferrario, Margherita Maffioli, Luca Arcaini & Francesco Passamonti. (2015) Everolimus in diffuse large B-cell lymphomas. Future Oncology 11:3, pages 373-383.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.